Blog - Latest News

You are here: Home » General Biotechnology » Journal of Commercial Biotechnology — May 2011 issue now availab...
April 27, 2011
27 Apr 2011

Journal of Commercial Biotechnology — May 2011 issue now available

The May 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 17, Issue 2

Editorial

Building biotechnology in Okinawa PDF
Yali Friedman

Commentary

Startup America: What it includes and opportunities for innovators PDF
David B Orange
Singapore – Home base for expansion in Asia PDF
Kian-Teik Beh
Traditional ecological knowledge: Impact on commercial health PDF
Mohammadali Khalvati, Ikway (Yvonne Fulton) Michine, Wabiska (Zane Bell) Mukwa, Mary Jane Metatawabin

Articles

The growing importance of incorporating US payers into biotechnology drug development decision-making PDF
Sarah Collins
Anticipating opportunities in industrial biotechnology: Sizing the market and growth scenarios PDF
Peter J Nieuwenhuizen, David Lyon
Founding angels as early stage investment model to foster biotechnology start-ups PDF
Gunter Festel
The economic potential of plant-made pharmaceuticals in the manufacture of biologic pharmaceuticals PDF
James Kaufman, Nicholas Kalaitzandonakes

From the Classroom

Developing graduate skills for the United Kingdom’s commercial life science sector: Experiences from the ORBIS internship programme PDF
James Gazzard

Legal and Regulatory Updates

EU Legal and Regulatory Update PDF
Gerry Kamstra
Impact of recent IP caselaw on biomarkers and personalized medicine PDF
David A Gass
Licensing issues in today’s bankruptcy world PDF
Michael Schein, Brandon J Fleischman
Limitation of gene patents to functioning DNA PDF
Philip Webber

Book Reviews

Chronicling the development of myozyme: The Cure and Chasing Miracles PDF
Derek J Francis
Anatomy of a Patent Case PDF
Michael G Sullivan

0 Comments/7 Tweets/in General Biotechnology
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Get updates by email


 

BiotechBlog’s Editor

Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Read More...

Network and Share

Connect on LinkedIn
Join BiotechBlog on LinkedIn
Follow BiotechBlog on Twitter
Share BiotechBlog on LinkedIn  Tweet BiotechBlog on Twitter Email biotechnology policy, regulation, and law

Categories

Recommended Reading

Image of Great Patents: Advanced Strategies For Innovative Growth Companies
Image of Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine
Image of Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business
Image of Biotechnology Entrepreneurship From Science to Solutions -- Start-up, Company Formation and Organization, Team, Intellectual Property, Financing, ... Regulatory Affairs, Reimbursement, Exit
Image of Biotechnology Entrepreneurship Bootcamp: Journal of Commercial Biotechnology Special Issue
Image of The Life Science Innovation Roadmap: Bioscience Innovation Assessment, Planning, Strategy, Execution, and Implementation
Image of Revolutions: Paving the Way for the Bioeconomy
Image of Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science

Translator

© Copyright - BiotechBlog — A thinkBiotech product